Registry of Lobbyists
Version 1 of 43 (2007-07-13 to 2008-02-12) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd. Dorval, QC H9S 1A9 Canada |
| Telephone number: | 514-633-7880 Ext.: 3395 |
| Fax number: | 514-631-0307 |
| Responsible officer name and position during the period of this registration: | David Meek, President |
| Description of activities: | Marketing & distribution of pharmaceuticals products. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Alain Boisvert |
| Position title: | VP, Health Policy & Market Access |
| Public offices held: | No |
| Name: | Shona Kinley |
| Position title: | Director, Health Policy - Atlantic Canada & Federal |
| Public offices held: | Yes |
| Name: | Patricia Manzi |
| Position title: | National Director, Health Policy |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Atlantic Canada Opportunities Agency (ACOA), Fisheries and Oceans Canada (DFO), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), National Defence (DND), Veterans Affairs Canada (VAC) | ||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, Science and Technology | ||||||||
| Subject Matter: Retrospective: | Intellectual Property re: Data protection | ||||||||
| Subject Matter: Prospective: | Develop business relationships and discuss the innovation agenda and other Novartis federal isses as they arise. | ||||||||
Details Regarding the Identified Subject Matter
|
|||||||||